Eric Springman

Eric Springman has over two decades of experience in the pharmaceutical industry, specializing in arthritis and fibrosis therapy. Eric began their career as a group leader at Arris / Axys Pharmaceuticals in 1995. In 1998, they became head of arthritis and fibrosis therapy at Roche Pharmaceuticals. In 2001, they moved to Locus Pharmaceuticals as head of discovery and development, where they stayed until 2009. Eric is currently a scientific advisor at Vibliome Therapeutics.

Eric Springman received a bachelor's degree in chemistry/biology from Florida Atlantic University. Eric then went on to get their doctor of philosophy (Ph.D.) in molecular biophysics from Florida State University. Lastly, they completed a postdoctoral fellowship in allergy and immunology/clinical pharmacology at Vanderbilt University School of Medicine.